| Structure–activity relationship of benzofuran derivatives with potential anticancer activity J Farhat, L Alzyoud, M Alwahsh, B Al-Omari Cancers 14 (9), 2196, 2022 | 33 | 2022 |
| Physicochemical characteristics and bioactive compounds of different types of honey and their biological and therapeutic properties: a comprehensive review MA Al-Kafaween, M Alwahsh, AB Mohd Hilmi, DH Abulebdah Antibiotics 12 (2), 337, 2023 | 27 | 2023 |
| Transcending toward advanced 3D-cell culture modalities: a review about an emerging paradigm in translational oncology J Farhat, I Pandey, M AlWahsh Cells 10 (7), 1657, 2021 | 24 | 2021 |
| PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor … L Hamadneh, M Bahader, R Abuarqoub, M AlWahsh, A Alhusban, ... Breast Cancer 28 (6), 1358-1366, 2021 | 18 | 2021 |
| Second exposure to acetaminophen overdose is associated with liver fibrosis in mice M AlWahsh, A Othman, L Hamadneh, A Telfah, J Lambert, S Hikmat, ... EXCLI journal 18, 51, 2019 | 14 | 2019 |
| In vitro spatio-temporal NMR metabolomics of living 3D cell models R Knitsch, M AlWahsh, H Raschke, J Lambert, R Hergenröder Analytical Chemistry 93 (40), 13485-13494, 2021 | 12 | 2021 |
| Metabolic profiling of thymic epithelial tumors hints to a strong Warburg effect, glutaminolysis and precarious redox homeostasis as potential therapeutic targets M Alwahsh, R Knitsch, R Marchan, J Lambert, C Hoerner, X Zhang, ... Cancers 14 (6), 1564, 2022 | 11 | 2022 |
| Bortezomib advanced mechanisms of action in multiple myeloma, solid and liquid tumors along with its novel therapeutic applications M Alwahsh, J Farhat, S Talhouni, L Hamadneh, R Hergenröder EXCLI journal 22, 146, 2023 | 10 | 2023 |
| Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth M Keller, K Rohlf, A Glotzbach, G Leonhardt, S Lüke, K Derksen, ... Journal of Experimental & Clinical Cancer Research 42 (1), 25, 2023 | 6 | 2023 |
| Glycolytic flux control by drugging phosphoglycolate phosphatase E Jeanclos, J Schlötzer, K Hadamek, N Yuan-Chen, M Alwahsh, ... Nature Communications 13 (1), 6845, 2022 | 3 | 2022 |
| An overview of ATP synthase, inhibitors, and their toxicity AR Althaher, M Alwahsh Heliyon, 2023 | 2 | 2023 |
| Synthesis of microwave-assisted carboxamides in Triton WR-1339-induced hyperlipidemic rats: possible hypolipidemic heterocyclic compounds B Al-Jammal, B Hussein, Y Al-Hiari, T Al-Qirim, M Al-Najdawi, ... RSC advances 13 (32), 22193-22204, 2023 | 1 | 2023 |
| The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment M Alwahsh, R Alejel, A Hasan, H Abuzaid, T Al-Qirim Metabolites 14 (8), 438, 2024 | | 2024 |
| Substituted furan-carboxamide and Schiff base derivatives as potential hypolipidemic compounds: evaluation in Triton WR-1339 hyperlipidemic rat model B Hussein, M Alwahsh, Y Al-Hiari, L Bourghli, B Al-Jammal, T Al-Qirim, ... Medicinal Chemistry Research, 1-14, 2024 | | 2024 |
| NMR-based metabolomics identification of potential serum biomarkers of disease progression in patients with multiple sclerosis M Alwahsh, RM Nimer, LA Dahabiyeh, L Hamadneh, A Hasan, R Alejel, ... Scientific Reports 14 (1), 14806, 2024 | | 2024 |
| Enamino Barbiturates as Antiproliferative and Antimicrobial Agents: Studies on Synthesis, Biological Activities, and Molecular Modeling M Shtaiwi, AH Abu Sarhan, N Aljaar, A Shtaiwi, M Abu‐Sini, M Alwahsh, ... ChemistrySelect 9 (18), e202400626, 2024 | | 2024 |
| Synthesis of some sulfonamide derivatives coupled with salicylamide or anisamide scaffold as potent PD-L1 inhibitors and their anti-proliferation assay NM Abdelazeem, M Alwahsh, AMF Galal, S Talhouni, L Hamadneh, ... Egyptian Journal of Chemistry 67 (5), 285-305, 2024 | | 2024 |
| Chitosan-Based Nanocarriers for Pulmonary and Intranasal Drug Delivery Systems: A Comprehensive Overview of their Applications W Alwahsh, S Sahudin, H Alkhatib, M F. Bostanudin, M Alwahsh Current Drug Targets 25 (7), 492 - 511, 2024 | | 2024 |
| Cytotoxic and molecular differences of anticancer agents on 2D and 3D cell culture M Alwahsh, A Al‑Doridee, S Jasim, O Awwad, R Hergenröder, ... Molecular Biology Reports 51, 721, 2024 | | 2024 |
| Synthesis and lipid-lowering properties of novel N-(4-benzoylphenyl) pyrrole-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats T Al-Qirim, AQ Al Bawab, Y Al-Hiari, NH Ahmad, M Alwahsh, S Al-Kouz, ... Journal of Applied Pharmaceutical Science 14 (3), 064-070, 2024 | | 2024 |
